In this Article, we report a novel methodology that uses a commercially available PGM, but link it with functional DNA sensors to detect and quantify a broad range of non-glucose targets involved in diagnosis and environmental monitoring. These targets range from recreational drugs such as cocaine to important biological cofactors such as adenosine, as well as disease markers (for example, interferon-g for tuberculosis) and toxic metal ions (for example, uranium).